Myo-inositol administration positively affects hyperinsulinemia and hormonal parameters in overweight patients with polycystic ovary syndrome.
Gynecol Endocrinol. 2008 Mar;24(3):139-44. doi: 10.1080/09513590801893232.
Gynecol Endocrinol. 2008.
PMID: 18335328
Clinical Trial.